Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2016 | 03-2015 | 03-2014 | 03-2013 | 03-2012 | |
| Sales | 12,498 | 5,015 | 4,601 | 3,404 | 2,424 |
| Cost of Goods | 4,484 | 3,014 | 3,236 | 2,315 | 1,014 |
| Gross Profit | 8,014 | 2,002 | 1,365 | 1,088 | 1,410 |
| Operating Expenses | 16,815 | 18,522 | 6,885 | 2,967 | 3,390 |
| Operating Income | -8,317 | -16,507 | -5,284 | -1,563 | -1,966 |
| Interest Expense | 281 | 287 | 900 | 393 | 654 |
| Other Income | 7,394 | 22,012 | -35,370 | 3,090 | -12,922 |
| Pre-tax Income | -1,204 | 5,217 | -41,554 | 1,134 | -15,542 |
| Income Tax | -521 | -3 | -293 | -354 | -484 |
| Net Income Continuous | -683 | 5,221 | -41,261 | 1,488 | -15,058 |
| Net Income | $-683 | $5,221 | $-41,261 | $1,488 | $-15,058 |
| EPS Basic Total Ops | -0.01 | 0.05 | -0.21 | 0.00 | -0.06 |
| EPS Basic Continuous Ops | 0.00 | 0.01 | -0.09 | 0.00 | -0.06 |
| EPS Diluted Total Ops | -0.01 | -0.02 | -0.21 | 0.00 | -0.06 |
| EPS Diluted Continuous Ops | 0.00 | 0.01 | -0.09 | 0.00 | -0.06 |
| EBITDA(a) | $-7,650 | $-15,925 | $-4,830 | $-1,140 | $-1,482 |